Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,921 | -8,057 | -83,784 | -51,924 | -36,478 |
| Depreciation Amortization | 4,302 | 2,399 | 11,543 | 8,664 | 5,777 |
| Accounts receivable | 8,437 | 10,896 | -10,372 | -4,413 | -4,476 |
| Other Working Capital | -15,489 | -12,388 | 12,184 | -6,951 | -4,073 |
| Other Operating Activity | 9,424 | -7,656 | 17,997 | 10,661 | 7,936 |
| Operating Cash Flow | $-24,247 | $-14,806 | $-52,432 | $-43,963 | $-31,314 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -264 | -52 | -562 | -477 | -242 |
| Investing Cash Flow | $-264 | $-52 | $-562 | $-477 | $-242 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 54,337 | N/A | N/A | N/A | N/A |
| Debt Repayment | -48,905 | -8 | -26 | -21 | -14 |
| Common Stock Issued | 5,440 | 4,760 | 103,464 | 102,781 | 21,293 |
| Other Financing Activity | -9,040 | -329 | -821 | -803 | -733 |
| Financing Cash Flow | $1,832 | $4,423 | $102,617 | $101,957 | $20,546 |
| Beginning Cash Position | 121,169 | 121,169 | 71,546 | 71,546 | 71,546 |
| End Cash Position | 98,490 | 110,734 | 121,169 | 129,063 | 60,536 |
| Net Cash Flow | $-22,679 | $-10,435 | $49,623 | $57,517 | $-11,010 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,247 | -14,806 | -52,432 | -43,963 | -31,314 |
| Capital Expenditure | -264 | -52 | -562 | -477 | -242 |
| Free Cash Flow | -24,511 | -14,858 | -52,994 | -44,440 | -31,556 |